Prior studies from Zhao et al. have noted the importance of fatty acid metabolism in ccRCC progress and focused on certain multiple fatty acid metabolic enzymes including CPT1A, HADHA, HADHB, and ACAT1 while no extra multiomics data or clinical treatment cohorts were incorporated [12]. This evidence concerns the gene HADHA and nonpapillary renal cell carcinoma.